Supernus makes depression drug play with $795m Sage buyout

finance.yahoo.com/news/supernus-makes-depression-drug-play-154330772.html

In This Article:
Fewer than five months after rejecting a takeover approach by Biogen, Sage Therapeutics has found a buyer in Supernus Pharmaceuticals.
According to the deal, Supernus will pay up to $795m to acquire depression treatment specialist Sage. The contract value significantly…

This story appeared on finance.yahoo.com, 2025-06-16 15:43:30.
The Entire Business World on a Single Page. Free to Use →